Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Research

Community Prescribing and Resistant Streptococcus pneumoniae

Galia Barkai*, David Greenberg*, Noga Givon-Lavi*, Eli Dreifuss†, Daniel Vardy†, and Ron Dagan*Comments to Author 
Author affiliations: *Soroka University Medical Center and Ben-Gurion University of the Negev, Beer-Sheva, Israel; †Israel General Health Insurance Plan, Beer-Sheva, Israel

Main Article

Table

Antimicrobial drug prescriptions among Bedouin and Jewish children <5 years of age, southern Israel, 1998–2003

Antimicrobial agent Bedouin children
 Jewish children
Total prescriptions Mean ± SD yearly prescription rate/1,000 children Total prescriptions Mean ± SD yearly prescription rate/1,000 children Mean ± SD yearly difference (Bedouin children vs. Jewish children)/prescription/1,000 children p value
Amoxicillin 89,598 2,269 ± 266 54,090 1,480 ± 264 789 ± 175 <0.001
Amoxicillin-clavulanate 27,729 703 ± 91 12,173 335 ± 88 368 ± 51 <0.001
Phenoxymethyl penicillin 3,187 84 ± 47 3,609 101 ± 47 –16 ± 10 0.012
Cephalosporins* 18,625 471 ± 69 5,751 155 ± 34 316 ± 66 <0.001
Erythromycin 3,492 92 ± 51 2,256 64 ± 45 28 ± 66 0.002
Azithromycin 6,958 167 ± 108 8,998 236 ± 124 –70 ± 49 0.018
Total 149,589 3,787 ± 442 86,877 2,371 ± 315 1,416 ± 224 <0.001

*Cefaclor, cephalexin monohydrate, and cefuroxime-axetil.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external